The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer J. R. de la CourtA. H. W. BrunsJ. Heijmans Guidelines Open access 14 October 2022 Pages: 2063 - 2098
Performance Evaluation of the Microfluidic Antigen LumiraDx SARS-CoV-2 and Flu A/B Test in Diagnosing COVID-19 and Influenza in Patients with Respiratory Symptoms Jayne E. EllisPoppy GuestAndrew McCulloch Original Research Open access 24 September 2022 Pages: 2099 - 2109
Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study Lorena De La MoraMaría J. NebotJosep Mallolas Original Research Open access 29 September 2022 Pages: 2111 - 2124
Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19 Jessica J. JalbertMohamed HusseinWenhui Wei Original Research Open access 01 October 2022 Pages: 2125 - 2139
PCV13 Pediatric Routine Schedule Completion and Adherence Before and During the COVID-19 Pandemic in the United States Liping HuangJennifer L. NguyenAdriano Arguedas Original Research Open access 10 October 2022 Pages: 2141 - 2158
Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial Maria J. G. T. VehreschildPetar AtanasovAndreas R. Muehler Original Research Open access 15 October 2022 Pages: 2159 - 2176
Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study—The ARTHR-IS Study Group Reinaldo EspíndolaVenanzio VellaThe ARTHR-IS Group Original Research Open access 15 October 2022 Pages: 2177 - 2203
Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial Sanjeev SinhaAnuj AjayababuRavindra Mohan Pandey Original Research Open access 15 October 2022 Pages: 2205 - 2217
Incidence, Clinical Features, and Association with Prognosis of Bloodstream Infection in Pediatric Patients After Percutaneous or Surgical Treatment for Ventricular Septal Defect or Atrial Septal Defect: A Retrospective Cohort Study Qinchang ChenJinjin YuShushui Wang Original Research Open access 15 October 2022 Pages: 2219 - 2232
Follow-Up of Newborns with Hepatitis B Antigenemia Jing QiHuijuan LiuPan Zhao Original Research Open access 25 October 2022 Pages: 2233 - 2240
Disease Progression of Hospitalized Elderly Patients with Omicron BA.2 Treated with Molnupiravir Yayun LiuLingling GeXuesong Liang Original Research Open access 30 October 2022 Pages: 2241 - 2251
International Validation of a Methicillin-Resistant Staphylococcus aureus Risk Assessment Tool for Skin and Soft Tissue Infections E. J. ZasowskiT. D. TrinhMichael J. Rybak Original Research Open access 01 November 2022 Pages: 2253 - 2263
Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials Desmond CurranSean MatthewsKenneth Schmader Original Research Open access 02 November 2022 Pages: 2265 - 2277
Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic Marc ScherlingerCédric LemogneJean Sibilia Brief Report Open access 26 September 2022 Pages: 2279 - 2285
Exploring the Role of Antiviral Nasal Sprays in the Control of Emerging Respiratory Infections in the Community Christoforos HadjichrysanthouAnna L. BeukenhorstFrank de Wolf Brief Report Open access 30 October 2022 Pages: 2287 - 2296
Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants Caroline PerryMohammad HossainSalim Janmohamed Study Protocol Open access 21 October 2022 Pages: 2297 - 2310
Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports Xiao-Shan ZhangYu-Zhen WangCong-Rong Tang Case Report Open access 08 April 2022 Pages: 2311 - 2319
Correction to: Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports Xiao-Shan ZhangYu-Zhen WangCong-Rong Tang Correction Open access 05 November 2022 Pages: 2321 - 2321